Mental Health in Menopause: Mood, Anxiety and Brain Fog

Mood changes are common during the menopause transition, and perimenopause in particular appears to be a window of increased vulnerability to depressive symptoms. This is not imagination and not simply a reaction to getting older. It is also not something to accept without help: several effective treatments exist, and the right one depends on what is actually happening.

What people actually describe

The language of clinical categories often fails to capture what people report. Common experiences include:

• Low mood, flatness, or losing interest in things that used to matter
• Anxiety that feels new, or markedly worse than before
• Irritability and sudden anger that feels disproportionate and unlike you
• Loss of confidence, particularly at work, sometimes severe enough to change career decisions
• Tearfulness without an obvious trigger
• A sense of detachment, or of not recognising yourself
• Difficulty concentrating, word finding problems and forgetfulness, commonly called brain fog

Loss of confidence deserves emphasis, because it is rarely listed as a symptom and is one of the most frequently reported. People step back from promotions, presentations or public roles, and attribute it to a personal failing rather than a physiological transition.

Why does this happen?

Several mechanisms operate at once, and separating them cleanly is not always possible.

• Fluctuating estrogen. Estrogen interacts with serotonin and other neurotransmitter systems. In perimenopause the pattern is erratic fluctuation rather than a steady decline, and instability appears to matter more than absolute level.
• Disrupted sleep. Night sweats and insomnia fragment sleep, and poor sleep independently worsens mood, anxiety and concentration. This is often the largest single contributor.
• Symptom burden. Living with hot flashes, pain, heavy bleeding or urinary symptoms is wearing in itself.
• Life stage. Midlife frequently coincides with ageing parents, adolescent or departing children, career pressure, and bereavement. These are real stressors, not excuses that make the hormonal contribution imaginary.

Perimenopause is the higher risk window

Evidence suggests the risk of depressive symptoms is elevated during perimenopause specifically, more so than in the years before it or well after it. This is clinically important for two reasons.

First, perimenopause can begin years before periods stop and while cycles are still regular enough that menopause is not considered. Mood change may be the first noticeable feature, arriving before hot flashes or cycle changes. Second, because it is a window rather than a permanent state, the outlook for many people improves as the transition completes.

Who is at higher risk?

• Previous depression, anxiety or bipolar disorder
• A history of premenstrual dysphoric disorder, or marked mood sensitivity to cycles
• Postnatal depression in the past
• Early menopause, premature ovarian insufficiency, or menopause induced by surgery or cancer treatment
• Significant sleep disruption
• Concurrent life stressors, isolation, or lack of support
• Difficult or traumatic past experiences, which midlife can bring back into focus

Surgical menopause deserves particular mention. Removal of the ovaries produces an abrupt hormonal change rather than a gradual one, and the psychological impact is frequently underestimated in the aftermath of surgery.

Brain fog

Cognitive complaints in the menopause transition are well documented, most consistently affecting verbal memory, word finding and the ability to sustain attention. Reassuringly, for most people this is a transitional difficulty rather than the beginning of decline, and cognition tends to stabilise after the transition.

Sleep deprivation, anxiety and hot flashes all impair concentration in their own right, so improving those often improves the fog. If memory problems are progressive, if they interfere with familiar daily tasks, or if others are noticing them more than you are, that should be assessed rather than attributed to menopause.

Is this menopause or is this depression?

The distinction matters because it changes treatment, and the two overlap substantially. Depression is more likely when symptoms are persistent rather than fluctuating, when they are present most of the day nearly every day for at least two weeks, when there is loss of pleasure in nearly everything, and when there are marked changes in appetite, worthlessness or guilt.

You do not need to resolve this question yourself before seeking help. Describing what you experience, when it started, how it relates to your cycle if you still have one, and how it affects daily function gives a clinician what they need.

If you are having thoughts of harming yourself

Please seek help now rather than waiting for an appointment. Contact your local emergency number, go to an emergency department, or contact a crisis line in your country. In the UK you can call 999, or Samaritans free on 116 123 at any hour. In the US you can call or text 988 for the Suicide and Crisis Lifeline. These thoughts are a medical emergency, not a weakness, and they can be treated.

What treatments have evidence?

One point is worth taking to an appointment. Guidance from NICE advises that antidepressants should not be offered as first line treatment for low mood arising as part of the menopause in the absence of a diagnosis of depression. Antidepressants are genuinely effective where depression is present, but many people report being offered them without menopause being considered at all. It is reasonable to ask directly whether your symptoms could be related to perimenopause.

Where hormone therapy fits

Hormone therapy can help mood symptoms arising during perimenopause, particularly when they occur alongside hot flashes, night sweats and disrupted sleep. It is not established as a treatment for clinical depression by itself, and it is not a substitute for psychological therapy or antidepressants where those are indicated.

If you have a history of premenstrual dysphoric disorder or postnatal depression, mention it, since sensitivity to hormonal change may be relevant to both your risk and how you respond. For those with early menopause or premature ovarian insufficiency, hormone therapy is generally recommended until at least the average age of natural menopause for reasons that extend beyond mood. Our HRT section discusses the options in more detail.

Sleep is often the lever

If your sleep is broken by night sweats, addressing those directly may do more for mood than any intervention aimed at mood itself. Practical measures include a cooler bedroom, layered bedding, breathable nightwear, limiting alcohol in the evening, and a consistent wake time.

Where insomnia has become established and persists even on nights without sweats, cognitive behavioural therapy for insomnia has strong evidence and is generally preferred to long term sleeping tablets. Ask whether it is available to you, including through digital programmes.

Alcohol

Alcohol use often rises quietly in midlife, and it is frequently used to manage anxiety or to get to sleep. It is worth naming because it works against you on several fronts at once: it fragments sleep in the second half of the night, worsens anxiety the following day, can trigger hot flashes, and raises blood pressure. Reducing it is one of the more reliably effective changes available, and if it feels difficult to reduce, that is itself worth discussing rather than concealing.

What helps day to day

• Regular physical activity, including both aerobic exercise and strength work
• Daylight exposure early in the day, which supports sleep timing and mood
• Consistent wake times, even after poor nights
• Structured worry or planning time, rather than open ended rumination
• Maintaining social contact, which tends to contract exactly when it is most needed
• Naming what is happening to the people close to you, which reduces the sense of unexplained personality change
• Being specific at work about what would help, rather than absorbing the difficulty privately

What to ask at your appointment

• Could these symptoms be related to perimenopause?
• How do we distinguish this from depression, and does that change treatment?
• What is available locally for talking therapy, and how do I access it?
• Is cognitive behavioural therapy for insomnia available to me?
• Given my history, would hormone therapy be appropriate, and what would we monitor?
• If an antidepressant is suggested, why this one, and has menopause been considered?
• When should we review whether this is working?

When to seek help promptly

• Thoughts of harming yourself, or that others would be better off without you
• Symptoms persisting most of the day, nearly every day, for two weeks or more
• Being unable to function at work or care for yourself or dependants
• Rapidly worsening mood, or a marked change from your usual self
• Memory problems that are progressive or interfere with familiar tasks
• Increasing reliance on alcohol or other substances to cope

FAQs

Can perimenopause cause anxiety even if I have never been anxious?

Yes. New onset anxiety is a frequently reported feature of the transition, and can appear before cycle changes or hot flashes. It should still be assessed rather than assumed, since thyroid problems and other conditions can present similarly.

Is brain fog a sign of dementia?

For most people, no. Cognitive changes in the transition typically affect verbal memory and word finding and tend to stabilise afterwards. Progressive memory loss, or difficulty with familiar everyday tasks, is different and should be assessed.

Will HRT fix my mood?

It can help mood symptoms arising during perimenopause, especially alongside other menopausal symptoms and disrupted sleep. It is not established as a standalone treatment for clinical depression, and for some people therapy or antidepressants are the more appropriate route.

My doctor offered antidepressants without mentioning menopause. Is that right?

It may be appropriate if you have diagnosed depression, but guidance advises against antidepressants as a first line for low mood arising as part of the menopause where depression has not been diagnosed. It is reasonable to ask whether perimenopause has been considered.

Why am I so angry?

Irritability and disproportionate anger are commonly reported and are frequently compounded by sleep deprivation. It is a recognised feature of the transition rather than a character change, and it usually improves when sleep and other symptoms are addressed.

Does this ever end?

For many people mood symptoms improve as the transition completes, since perimenopause appears to be the period of greatest vulnerability. That is not a reason to wait it out without help, particularly as the transition can last several years.

I had postnatal depression years ago. Does that matter now?

It is worth mentioning. A history of postnatal depression or premenstrual dysphoric disorder suggests sensitivity to hormonal change, which may be relevant both to your risk during this transition and to how your care is planned.

Should I tell my employer?

That is a personal decision and depends on your workplace. Many people find that requesting specific adjustments, such as flexibility around sleep-disrupted periods, temperature control, or scheduling demanding tasks at better times, is more effective than a general disclosure. Our Life and work section covers this in more detail.

Bottom line

Mood, anxiety and cognitive changes are genuine features of the menopause transition, with perimenopause carrying the highest risk. They are not a character flaw or an inevitable part of ageing to be endured. Sleep is frequently the underlying driver and often the most productive thing to address first. Cognitive behavioural therapy has good evidence, hormone therapy can help mood arising in perimenopause, and antidepressants are appropriate where depression is diagnosed but are not the automatic first answer. If you are having thoughts of harming yourself, treat that as an emergency and seek help immediately.

References

1. National Institute for Health and Care Excellence. Menopause: identification and management (NG23). Published 12 November 2015, last updated 15 April 2026. nice.org.uk
2. The Menopause Society (formerly The North American Menopause Society). The 2023 nonhormone therapy position statement (Position statement). Published 2023. menopause.org

Sources verified 10 September 2026. Clinical guidance is updated periodically, and availability of specific treatments differs by country, so check current national guidance. This article is general information and does not replace individual medical advice.